Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Endonovo Therapeutics, Inc. (ENDV) Message Board

Found some interesting possible connections on Ala

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 416
(Total Views: 395)
Posted On: 09/11/2017 8:04:22 AM
Posted By: CyberSea
Found some interesting possible connections on Alan Colliers linkedin page. He is following 7 companies, 2 he is CEO of, 2 are the schools he attended, 1 is Virgin Galactic (Branson is also listed as influenced by), and the last two which are possibly relevant to the company. The first is Charles River Laboratories, the largest provider of pre clinical and clinical support in the world. The second is Stemcyte cord blood bank, one of the largest providers of core blood in the world.

https://www.linkedin.com/in/collieralan/detai...companies/

Obvious what the connection may be to Charles River Laboratories but a little research into Stemcyte really got me thinking.

Stemcyte is extracting and expanding stem cells derived from umbilical cord blood. As I researched the processes they are using and the expansion rates it was clear how Endonovo could be on the radar of this company. The are using a starch based solution with sugars, proteins and biologics to create a natural replication environment. It is a slow process which is creating 2 dimensional stem cells. They are bragging about an expansion rate of 14-44 fold.

If you are familiar with the Cytotronics platform you know that Endonovo is able to produce biologically superior stem cells in a 6 day period with an 80 fold expansion rate and because they are grown in a non gravitational atmosphere the are 3 dimensional cells.

I wonder if Stemcyte would be interested in doubling their expansion rate in a much quicker time frame. In 2015 Endonovo announces a corporate licensing program which in addition to licensing the technology also sought partnerships for development. They filed patents and continuation patents shortly after.

On Stemcyte's company description under current projects is this statement, "StemCyte is actively involved in the development of new umbilical cord blood-based cell therapies". Now to me there are a few key words in that statement, "involved in" and "new". If this was a project that was solely being run by Stemcyte it would be phrased is developing not involved in development. The new would definitely classify a technology that is less than 2 years old.

Look at the description on the patent Endonovo applied for in Oct 2015.
The perivascular cell mixture (the "Cell Mixture" is created using the Company's Cytotronics™ platform and the co-culture of immunologically privileged and modulatory stem cells from a portion of the human umbilical cord along with adipose stem cells and a mixture of cord blood cells to create an off-the-shelf therapeutic product that can be stored indefinitely in a low temperature freezer and used to treat blood-related disorders.

This patent is right at the 2 year time frame and could be granted any day now.

Some things to ponder as we wait for these preclinical results of the Immunotronics platform, which honestly is just a portion of the huge potential this unique company holds.

https://www.linkedin.com/company/155607/

http://www.otcmarkets.com/stock/ENDV/news/End...48&b=y

http://www.otcmarkets.com/stock/ENDV/news/End...08&b=y

http://www.otcmarkets.com/stock/ENDV/news/End...44&b=y


(0)
(0)




Endonovo Therapeutics, Inc. (ENDV) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us